Global Influenza Diagnostics Market Size, Share, Trends & Growth Analysis Report 2026-2034

Description

The Influenza Diagnostics Market size is expected to reach USD 2.87 Billion in 2034 from USD 1.52 Billion (2025) growing at a CAGR of 7.31% during 2026-2034.

The global influenza diagnostics market has grown due to increased awareness about infectious diseases. Seasonal flu outbreaks and the need for early detection have boosted demand for diagnostic tests. Healthcare providers focus on quick and accurate testing to prevent the spread of infection. The COVID-19 pandemic also strengthened diagnostic infrastructure worldwide.

Key drivers include technological advancements in rapid testing kits and molecular diagnostics. Growing healthcare spending and government initiatives for disease surveillance support market growth. Hospitals and diagnostic laboratories are expanding their testing capabilities. Increasing public awareness about timely diagnosis further drives demand.

In the future, the market is expected to expand with the development of more accurate and portable testing solutions. Investment in research and public health programs will create opportunities. However, seasonal demand fluctuations may affect revenue stability. Despite this, rising focus on disease prevention and preparedness will support long-term growth.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

MARKET SEGMENTATION

By Product

Test Kits
Instruments

By Test

Traditional Diagnostic Test
Rapid influenza detection tests
Serological assays
Direct fluorescent antibodies
Viral culture
H1N1 influenza A virus identification kits
Molecular Diagnostic Tests
Polymerase Chain Reaction
Isothermal Nucleic Acid Amplification Tests
Transcription-Mediated Amplification-Based Assay
Loop-Mediated Isothermal Amplification-Based Assay
Nucleic Acid Sequence-Based Amplification Tests
Other Isothermal Nucleic Acid Amplification Tests
Others

By Type

Type A Flu
Type B Flu
Type C Flu

By End-Use

Hospitals
Clinical Laboratories
Research and Academic Institutes
Contract Research Organizations

COMPANIES PROFILED

Abbott Laboratories, Becton, Dickinson and Company BD, F HoffmannLa Roche Ltd, Thermo Fisher Scientific Inc, Hologic Inc, Siemens Healthineers, Quidel Corporation, bioMrieux, Meridian Bioscience Inc, DiaSorin SpA, Sekisui Diagnostics, Luminex Corporation, Tecan Trading AG, altona Diagnostics GmbH, GenMark Diagnostics Inc
We can customise the report as per your requirements.

Product Code: VMR11210909

Chapter 1. PREFACE

1.1. Market Segmentation & Scope
1.2. Market Definition
1.3. Information Procurement
- 1.3.1 Information Analysis
- 1.3.2 Market Formulation & Data Visualization
- 1.3.3 Data Validation & Publishing
1.4. Research Scope and Assumptions
- 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

2.1. Market Snapshot
2.2. Segmental Outlook
2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

3.1. Market Lineage Outlook
3.2. Penetration & Growth Prospect Mapping
3.3. Value Chain Analysis
3.4. Regulatory Framework
- 3.4.1 Standards & Compliance
- 3.4.2 Regulatory Impact Analysis
3.5. Market Dynamics
- 3.5.1 Market Drivers
- 3.5.2 Market Restraints
- 3.5.3 Market Opportunities
- 3.5.4 Market Challenges
3.6. Porter's Five Forces Analysis
3.7. PESTLE Analysis

Chapter 4. GLOBAL INFLUENZA DIAGNOSTICS MARKET: BY PRODUCT 2022-2034 (USD MN and Units)

4.1. Market Analysis, Insights and Forecast Product
4.2. Test Kits Estimates and Forecasts By Regions 2022-2034 (USD MN and Units)
4.3. Instruments Estimates and Forecasts By Regions 2022-2034 (USD MN and Units)

Chapter 5. GLOBAL INFLUENZA DIAGNOSTICS MARKET: BY TEST 2022-2034 (USD MN and Units)

5.1. Market Analysis, Insights and Forecast Test
5.2. Traditional Diagnostic Test Estimates and Forecasts By Regions 2022-2034 (USD MN and Units)
5.3. Rapid influenza detection tests Estimates and Forecasts By Regions 2022-2034 (USD MN and Units)
5.4. Serological assays Estimates and Forecasts By Regions 2022-2034 (USD MN and Units)
5.5. Direct fluorescent antibodies Estimates and Forecasts By Regions 2022-2034 (USD MN and Units)
5.6. Viral culture Estimates and Forecasts By Regions 2022-2034 (USD MN and Units)
5.7. H1N1 influenza A virus identification kits Estimates and Forecasts By Regions 2022-2034 (USD MN and Units)
5.8. Molecular Diagnostic Tests Estimates and Forecasts By Regions 2022-2034 (USD MN and Units)
5.9. Polymerase Chain Reaction Estimates and Forecasts By Regions 2022-2034 (USD MN and Units)
5.10. Isothermal Nucleic Acid Amplification Tests Estimates and Forecasts By Regions 2022-2034 (USD MN and Units)
5.11. Transcription-Mediated Amplification-Based Assay Estimates and Forecasts By Regions 2022-2034 (USD MN and Units)
5.12. Loop-Mediated Isothermal Amplification-Based Assay Estimates and Forecasts By Regions 2022-2034 (USD MN and Units)
5.13. Nucleic Acid Sequence-Based Amplification Tests Estimates and Forecasts By Regions 2022-2034 (USD MN and Units)
5.14. Other Isothermal Nucleic Acid Amplification Tests Estimates and Forecasts By Regions 2022-2034 (USD MN and Units)
5.15. Others Estimates and Forecasts By Regions 2022-2034 (USD MN and Units)

Chapter 6. GLOBAL INFLUENZA DIAGNOSTICS MARKET: BY TYPE 2022-2034 (USD MN and Units)

6.1. Market Analysis, Insights and Forecast Type
6.2. Type A Flu Estimates and Forecasts By Regions 2022-2034 (USD MN and Units)
6.3. Type B Flu Estimates and Forecasts By Regions 2022-2034 (USD MN and Units)
6.4. Type C Flu Estimates and Forecasts By Regions 2022-2034 (USD MN and Units)

Chapter 7. GLOBAL INFLUENZA DIAGNOSTICS MARKET: BY END-USE 2022-2034 (USD MN and Units)

7.1. Market Analysis, Insights and Forecast End-use
7.2. Hospitals Estimates and Forecasts By Regions 2022-2034 (USD MN and Units)
7.3. Clinical Laboratories Estimates and Forecasts By Regions 2022-2034 (USD MN and Units)
7.4. Research and Academic Institutes Estimates and Forecasts By Regions 2022-2034 (USD MN and Units)
7.5. Contract Research Organizations Estimates and Forecasts By Regions 2022-2034 (USD MN and Units)

Chapter 8. GLOBAL INFLUENZA DIAGNOSTICS MARKET: BY REGION 2022-2034(USD MN and Units)

8.1. Regional Outlook
8.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN and Units)
- 8.2.1 By Product
- 8.2.2 By Test
- 8.2.3 By Type
- 8.2.4 By End-use
- 8.2.5 United States
- 8.2.6 Canada
- 8.2.7 Mexico
8.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN and Units)
- 8.3.1 By Product
- 8.3.2 By Test
- 8.3.3 By Type
- 8.3.4 By End-use
- 8.3.5 United Kingdom
- 8.3.6 France
- 8.3.7 Germany
- 8.3.8 Italy
- 8.3.9 Russia
- 8.3.10 Rest Of Europe
8.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN and Units)
- 8.4.1 By Product
- 8.4.2 By Test
- 8.4.3 By Type
- 8.4.4 By End-use
- 8.4.5 India
- 8.4.6 Japan
- 8.4.7 South Korea
- 8.4.8 Australia
- 8.4.9 South East Asia
- 8.4.10 Rest Of Asia Pacific
8.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN and Units)
- 8.5.1 By Product
- 8.5.2 By Test
- 8.5.3 By Type
- 8.5.4 By End-use
- 8.5.5 Brazil
- 8.5.6 Argentina
- 8.5.7 Peru
- 8.5.8 Chile
- 8.5.9 South East Asia
- 8.5.10 Rest of Latin America
8.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN and Units)
- 8.6.1 By Product
- 8.6.2 By Test
- 8.6.3 By Type
- 8.6.4 By End-use
- 8.6.5 Saudi Arabia
- 8.6.6 UAE
- 8.6.7 Israel
- 8.6.8 South Africa
- 8.6.9 Rest of the Middle East And Africa

Chapter 9. COMPETITIVE LANDSCAPE

9.1. Recent Developments
9.2. Company Categorization
9.3. Supply Chain & Channel Partners (based on availability)
9.4. Market Share & Positioning Analysis (based on availability)
9.5. Vendor Landscape (based on availability)
9.6. Strategy Mapping

Chapter 10. COMPANY PROFILES OF GLOBAL INFLUENZA DIAGNOSTICS INDUSTRY

10.1. Top Companies Market Share Analysis
10.2. Company Profiles
- 10.2.1 Abbott Laboratories
- 10.2.2 Becton, Dickinson And Company (BD)
- 10.2.3 F. Hoffmann-La Roche Ltd
- 10.2.4 Thermo Fisher Scientific Inc
- 10.2.5 Hologic Inc
- 10.2.6 Siemens Healthineers
- 10.2.7 Quidel Corporation
- 10.2.8 BioMAfA(C)Rieux
- 10.2.9 Meridian Bioscience Inc
- 10.2.10 DiaSorin SpA
- 10.2.11 Sekisui Diagnostics
- 10.2.12 Luminex Corporation
- 10.2.13 Tecan Trading AG
- 10.2.14 Altona Diagnostics GmbH
- 10.2.15 GenMark Diagnostics Inc